International health officials say two experimental drugs used to treat Ebola infections appear to be saving lives in the Democratic Republic of the Congo (DRC). Dr. Anthony Fauci of the U.S. National Institutes of Health (NIH) called the early results “some very good news”. He said the new drugs may be able to improve the survival of people with Ebola. The NIH helped support the research.
The findings come from a study of four different drugs that started in November of last year. But an independent monitoring group recommended last week that all new patients should receive either of the two drugs that showed the best results.
____________________
The research was designed to test the effectiveness of the drugs on as many as 725 people infected with the Ebola virus in North Kivu and Ituri provinces. An outbreak of Ebola in those parts of the DRC has killed more than 1,800 people since August 2018. The recent study found that less than one-third of patients who were infected died when they took the two new drugs. Those patients who had low levels of the virus in their blood had even better results.
Dr. Ryan of the WHO said he hoped the results would persuade more patients to seek care as soon as symptoms appear. “Getting people into care more quickly is absolutely vital,” he said. However, treating the disease is becoming more difficult because the affected areas of the eastern DRC face ethnic conflict.
Jean-Jacques Muyembe, director general of the National Institute of Biomedical Research in DRC, helped lead the study. He said, “From now on, we will no longer say that Ebola is incurable.”
本时文内容由奇速英语国际教育研究院原创编写,未经书面授权,禁止复制和任何商业用途,版权所有,侵权必究!(作者投稿及时文阅读定制请联系微信:400-1000-028)